{"schema_version":"1","generated_at":"2026-11-20T10:09:12.968Z","data_as_of":null,"url":"https://www.findmykol.com/kol/gabriel-uwaifo","json_url":"https://www.findmykol.com/kol/gabriel-uwaifo/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"gabriel-uwaifo","name":"Gabriel Uwaifo","credential":"MD","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"institution":"Southern Illinois University School of Medicine","institution_url":"https://www.findmykol.com/institution/southern-illinois-university-school-of-medicine","city":"Springfield","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Gabriel Uwaifo is an Endocrinology/Metabolic physician affiliated with Southern Illinois University School of Medicine. OpenAlex indexes 374 publications with 11,173 citations (h-index 33).","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":374,"cited_by_count":11173,"h_index":33,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":17,"program_years":{"first":2021,"last":null},"rows_total":28,"shown":3,"withheld":25,"rows":[{"payer":"Eli Lilly","program_year":2025,"amount_usd":59571,"payment_count":1},{"payer":"Eli Lilly and Company","program_year":2025,"amount_usd":2851.7,"payment_count":22},{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2025,"amount_usd":1125,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":7,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":42.2,"classes_total":11,"classes":[{"class":"Biguanide (metformin)","setting":"prescribed","share_pct":11,"drugs":[{"name":"Metformin Hcl Er","share_pct":53.7},{"name":"Metformin Hcl","share_pct":46.3}],"max_beneficiaries":46},{"class":"GLP-1 receptor agonist","setting":"prescribed","share_pct":10.9,"drugs":[{"name":"Ozempic","share_pct":30.7},{"name":"Victoza 3-Pak","share_pct":22.4},{"name":"Trulicity","share_pct":17.8},{"name":"Mounjaro","share_pct":14.1},{"name":"Victoza 2-Pak","share_pct":8.7},{"name":"Rybelsus","share_pct":6.2}],"max_beneficiaries":null}]},{"area":"Hormonal (systemic)","share_pct":25.9,"classes_total":7,"classes":[{"class":"l-Thyroxine","setting":"prescribed","share_pct":20.6,"drugs":[{"name":"Levothyroxine Sodium","share_pct":79.9},{"name":"Synthroid","share_pct":20.1}],"max_beneficiaries":115},{"class":"Thyroid Hormone Synthesis Inhibitor","setting":"prescribed","share_pct":1.4,"drugs":[{"name":"Methimazole","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":16.6,"classes_total":7,"classes":[{"class":"Statin","setting":"prescribed","share_pct":7.7,"drugs":[{"name":"Atorvastatin Calcium","share_pct":49.4},{"name":"Pravastatin Sodium","share_pct":26.5},{"name":"Rosuvastatin Calcium","share_pct":24.1}],"max_beneficiaries":25},{"class":"ACE inhibitor","setting":"prescribed","share_pct":3.4,"drugs":[{"name":"Lisinopril","share_pct":100}],"max_beneficiaries":28}]}],"care_setting":{"dominant":"mixed","data_year":2023,"office_pct":55,"facility_pct":45},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial","year":2025,"journal":"The Lancet Diabetes & Endocrinology","source_url":"https://doi.org/10.1016/s2213-8587(25)00022-1","status":"verified"},{"title":"The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact","year":2025,"journal":"Diabetes Care","source_url":"https://doi.org/10.2337/dc25-0014","status":"verified"},{"title":"Edetate Disodium–Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes","year":2024,"journal":"JAMA","source_url":"https://doi.org/10.1001/jama.2024.11463","status":"verified"},{"title":"Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)","year":2024,"journal":"Journal of Clinical & Translational Endocrinology","source_url":"https://doi.org/10.1016/j.jcte.2024.100341","status":"verified"},{"title":"Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH","year":2023,"journal":"Diabetologia","source_url":"https://doi.org/10.1007/s00125-023-05922-7","status":"verified"}],"source":"works"},"similar":[{"name":"John Flack","slug":"john-flack","institution":"Southern Illinois University School of Medicine","specialty":"Hypertension Specialist","url":"https://www.findmykol.com/kol/john-flack","json_url":"https://www.findmykol.com/kol/john-flack/profile.json"},{"name":"Brendan Stack","slug":"brendan-stack","institution":"Southern Illinois University School of Medicine","specialty":"Plastic Surgery within the Head & Neck","url":"https://www.findmykol.com/kol/brendan-stack","json_url":"https://www.findmykol.com/kol/brendan-stack/profile.json"},{"name":"Rebecca Larson","slug":"rebecca-larson","institution":"Southern Illinois University School of Medicine","specialty":"MOHS-Micrographic Surgery","url":"https://www.findmykol.com/kol/rebecca-larson","json_url":"https://www.findmykol.com/kol/rebecca-larson/profile.json"},{"name":"Abdul Moiz Hafiz","slug":"abdul-moiz-hafiz","institution":"Southern Illinois University School of Medicine","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/abdul-moiz-hafiz","json_url":"https://www.findmykol.com/kol/abdul-moiz-hafiz/profile.json"},{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":25,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}